Main

processing priority

4

site type

3 (personal blog or private political site, e.g. Blogspot, Substack, also small blogs on own domains)

review version

11

html import

20 (imported)

Events

first seen date

2024-10-23 15:33:12

expired found date

-

created at

2024-10-23 15:33:12

updated at

2025-12-05 03:11:15

Domain name statistics

length

20

crc

7817

tld

2211

nm parts

0

nm random digits

0

nm rare letters

0

Connections

is subdomain of id

69893241 (blogspot.com)

previous id

0

replaced with id

0

related id

-

dns primary id

0

dns alternative id

0

lifecycle status

0 (unclassified, or currently active)

Subdomains and pages

deleted subdomains

0

page imported products

0

page imported random

0

page imported parking

0

Error counters

count skipped due to recent timeouts on the same server IP

0

count content received but rejected due to 11-799

0

count dns errors

0

count cert errors

0

count timeouts

0

count http 429

0

count http 404

0

count http 403

0

count http 5xx

0

next operation date

-

Server

server bits

server ip

-

Mainpage statistics

mp import status

20

mp rejected date

-

mp saved date

-

mp size orig

633225

mp size raw text

3760

mp inner links count

252

mp inner links status

10 (links queued, awaiting import)

Open Graph

title

NIPC Law

description

Articles, Case Notes, Presentations and In-depth Discussion of IP and Technology Law.

site name

author

updated

2026-02-27 00:38:00

raw text

NIPC Law Skip to main content Search This Blog NIPC Law Articles, Case Notes, Presentations and In-depth Discussion of IP and Technology Law. Home About News Profile Services Instructing Me User Guide Contact Me More… Posts Practice - Bayer IP v Aspire Pharma Get link Facebook Twitter Pinterest Email Other Apps October 18, 2024 Jane Lambert Patents Court (HH Judge Hacon) Bayer Intellectual Property GmbH and others v Aspire Pharma Ltd and others [2024] EWHC 711 (Pat) (27 March 2024) Rivaroxaban  is an anticoagulant medication used to treat and prevent blood clots, particularly deep vein thrombosis, pulmonary emboli and atrial fibrillation after hip or knee surgery.  Until the hearing of this application Bayer Intellectual Property GmbH, its holding and associated companies enjoyed a monopoly of the market for rivaroxaban in the UK, That was because Bayer Intellectual Property GmbH held a patent for the product as a compound which was exten...

Text analysis

redirect type

0 (-)

block type

0 (no issues)

detected language

1 (English)

category id

Pozostałe (16)

index version

1

spam phrases

0

Text statistics

text nonlatin

0

text cyrillic

0

text characters

2961

text words

566

text unique words

290

text lines

52

text sentences

15

text paragraphs

3

text words per sentence

37

text matched phrases

0

text matched dictionaries

0

RSS

rss status

32 (unknown)

rss found date

2024-10-23 15:33:14

rss size orig

212579

rss items

25

rss spam phrases

0

rss detected language

1 (English)

inbefore feed id

-

inbefore status

0 (new)

Sitemap

sitemap status

40 (completed successful import of reports.txt file to table in_pages)

sitemap review version

2

sitemap urls count

1234

sitemap urls adult

0

sitemap filtered products

0

sitemap filtered videos

0

sitemap found date

2024-10-23 15:33:13

sitemap process date

2024-10-23 15:33:16

sitemap first import date

-

sitemap last import date

2025-12-05 03:11:15